Healthleap raises $38 million for AI that flags missed conditions in hospital patients

Representative image: erwinbosman / Pixabay
Healthleap raised $38 million in seed and Series A funding on 7 October 2026 for AI that screens hospital records daily to flag undiagnosed conditions.
What Happened
Healthleap, a San Francisco start-up whose artificial intelligence reads hospital patient records to flag conditions that doctors may have missed, has raised 38 million dollars, the company announced on Wednesday, 7 October 2026. The total combines an 8 million dollar seed round co-led by Sequoia Capital and First Round Capital with a 30 million dollar Series A led by Hummingbird Ventures. Founded in 2022 by siblings Josiah and Jemima Meyer, Healthleap says its platform screens adult inpatients daily at more than 50 hospitals, including Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare. Its first focus is malnutrition among hospital patients.
Key Facts
- Healthleap announced 38 million dollars in combined funding on 7 October 2026.
- The total includes an 8 million dollar seed round co-led by Sequoia Capital and First Round Capital.
- A 30 million dollar Series A was led by Hummingbird Ventures.
- The company was founded in 2022 by siblings Josiah Meyer, its chief executive, and Jemima Meyer.
- Its software screens adult inpatients daily at more than 50 hospitals, according to the company.
- It started with malnutrition, a condition that is often overlooked in hospital patients, and plans to expand to other conditions.
- The money will go into engineering, sales, customer success and product teams.
Why It Matters
Busy hospital teams can miss conditions that are not the reason a patient was admitted. Malnutrition is the example Healthleap started with: a patient admitted for another reason may also be poorly nourished without it ever being formally recorded. Software that reviews every patient's record daily and flags those who need a closer look can help clinicians catch such problems earlier.
The model also shows where AI is finding a paying market in healthcare. Rather than replacing doctors, Healthleap's tool works in the background and hands a short list of patients to clinicians to check. The backing from Sequoia, First Round and Hummingbird suggests investors see this kind of practical, workflow-focused AI as a durable business.
For Indian founders building health-tech products, the story is a useful template: start with one clearly defined, measurable problem, prove results in real hospitals, and then expand to related conditions. Similar tools in India would depend on hospitals having good digital records, and data-privacy rules would shape how they can be used.
| Item | Detail |
|---|---|
| Total raised | 38 million dollars |
| Seed round | 8 million dollars, co-led by Sequoia Capital and First Round Capital |
| Series A | 30 million dollars, led by Hummingbird Ventures |
| Hospitals using it | More than 50 |
| First condition targeted | Malnutrition |
Impact
Short-term: Healthleap will hire across engineering, sales and product, and roll out its screening to more hospitals.
Long-term: If it expands successfully beyond malnutrition, tools like this could become a standard background check in hospitals, changing how often hidden conditions are caught and recorded.
Who is affected: Hospital patients, doctors and nurses, hospital administrators, health-tech investors, and founders building AI tools for clinical use.
Key Takeaway
Healthleap raised 38 million dollars on 7 October 2026 to grow AI that scans hospital records daily to flag missed conditions, starting with malnutrition.
Questions and Answers
What does Healthleap do?
It runs AI software that reads hospital patients' records every day and flags those who may have conditions that have not been diagnosed, starting with malnutrition, so clinicians can take a closer look.
How much did Healthleap raise, and from whom?
38 million dollars in total: an 8 million dollar seed round co-led by Sequoia Capital and First Round Capital, and a 30 million dollar Series A led by Hummingbird Ventures, announced on 7 October 2026.
Which hospitals use it?
The company says it screens patients at more than 50 hospitals, including Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare.
What can Indian health-tech founders learn from it?
Focus first on one measurable problem, prove results inside real hospitals, and expand step by step, while planning early for data quality and privacy requirements.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
Sourced and fact-checked by the Peepals Global Editorial Team
Nvidia in early talks to deepen Reflection AI stake or buy the open-model lab
Gujarat to use student-built tools in policing after e-Rakshak cyber hackathon
Reported, fact-checked and published by the Peepals Global Editorial Team.









